Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter "Elix") is pleased to announce that its AI drug discovery platform, Elix Discovery™ ( has been adopted by Eisai Co., Ltd. (Headquarters: ...